Literature DB >> 7692844

Characterization of Clara and type II cells isolated from rat lung by fluorescence-activated flow cytometry.

J Martin1, D Dinsdale, I N White.   

Abstract

A novel procedure for the isolation of Clara cells from rat lung is described. Single-cell suspensions from male F344/TOX rat lungs, prepared by subtilisin digestion, were treated with monochlorobimane (10 microM) and anlaysed by fluorescence-activated flow cytometry. A sub-population of about 2.8% of the total, showing the highest blue fluorescence and by inference the highest GSH concentration, was isolated as Clara cells of > 95% purity. Type II cells of similar purity were sorted after treatment with Phosphine 3R. Both sub-populations were > 90% viable, as judged by Trypan Blue exclusion. Comparison of CYP (cytochrome P-450) isoenzymes between these subpopulations, using Western blotting, showed CYP1A1 to be barely detectable. In Clara cells, CYP2B1 was 10-fold higher than in Type II cells. Mono-oxygenase activity towards the O-deethylation of 3-cyano-7-ethoxycoumarin was 2-fold higher in Clara cells. No activity was detected in macrophages. Pretreating rats with the mono-oxygenase inducers phenobarbitone, 3-methylcholanthrene or Aroclor 1254 showed the last-named to be the most potent inducer of CYP1A1. In Clara cells, CYP1A1 concentration and mono-oxygenase activities were induced > 2000- and 50-fold respectively, whereas in Type II cells increases of 300- and 3.6-fold were seen. Clara cells isolated from the lungs of control rats had a concentration of GSH (2.7 nmol/10(6) cells) that was 9- and 2-fold higher than that in Type II cells or macrophages respectively. GSH depleted by monochlorobimane treatment was restored after 2-3 h incubation with 0.2 M N-acetylcysteine. gamma-Glutamyltranspeptidase activity in Clara cells was 6- and 50-fold higher than in Type II cells or macrophages respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692844      PMCID: PMC1134822          DOI: 10.1042/bj2950073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  Xenobiotic metabolism by isolated pulmonary cells.

Authors:  T R Devereux; B A Domin; R M Philpot
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.

Authors:  J M Voigt; T T Kawabata; J P Burke; M V Martin; F P Guengerich; J Baron
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

3.  Isolation, biochemical characterization, and culture of lung type II cells of the rat.

Authors:  R J Richards; N Davies; J Atkins; V I Oreffo
Journal:  Lung       Date:  1987       Impact factor: 2.584

Review 4.  Detection and quantitation of biological sulfhydryls.

Authors:  A Russo; E A Bump
Journal:  Methods Biochem Anal       Date:  1988

5.  Primary structures of cytochrome P-450 isozyme 5 from rabbit and rat and regulation of species-dependent expression and induction in lung and liver: identification of cytochrome P-450 gene subfamily IVB.

Authors:  R Gasser; R M Philpot
Journal:  Mol Pharmacol       Date:  1989-05       Impact factor: 4.436

6.  A continuous fluorometric assay for cytochrome P-450-dependent mixed function oxidases using 3-cyano-7-ethoxycoumarin.

Authors:  I N White
Journal:  Anal Biochem       Date:  1988-08-01       Impact factor: 3.365

7.  Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450.

Authors:  I M Keith; E B Olson; N M Wilson; C R Jefcoate
Journal:  Cancer Res       Date:  1987-04-01       Impact factor: 12.701

8.  Toxic consequence of the abrupt depletion of glutathione in cultured rat hepatocytes.

Authors:  S Miccadei; M E Kyle; D Gilfor; J L Farber
Journal:  Arch Biochem Biophys       Date:  1988-09       Impact factor: 4.013

9.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

Authors:  I de Waziers; P H Cugnenc; C S Yang; J P Leroux; P H Beaune
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  3 in total

Review 1.  Lung injury: cell-specific bioactivation/deactivation of circulating pneumotoxins.

Authors:  D Dinsdale
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 2.  The Aryl Hydrocarbon Receptor (AHR): A Novel Therapeutic Target for Pulmonary Diseases?

Authors:  Binoy Shivanna; Chun Chu; Bhagavatula Moorthy
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 3.  The aryl hydrocarbon receptor as a target of environmental stressors - Implications for pollution mediated stress and inflammatory responses.

Authors:  Christoph F A Vogel; Laura S Van Winkle; Charlotte Esser; Thomas Haarmann-Stemmann
Journal:  Redox Biol       Date:  2020-04-18       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.